REGN:NASDAQ
Regeneron Pharmaceuticals Inc
$827.72
arrow_downward
-1.87%(-15.75) 1D
$827.72
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 4, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN...
Open
$840.06
High
$841.54
Low
$825.83
Mkt. cap
85.22B
Avg. vol.
762.48K
Volume
561.17K
Dividend
0.45%
Quarterly dividend
$0.94
Ex-dividend date
Aug 18, 2026
P/E ratio
20.46
52-wk high
$859.34
52-wk low
$541.00
EPS
$40.45
Beta
0.20
Shares outstanding
101.14M
No. of employees
15K
Open
$840.06
High
$841.54
Low
$825.83
Mkt. cap
85.22B
Avg. vol.
762.48K
Volume
561.17K
Dividend
0.45%
Quarterly dividend
$0.94
Ex-dividend date
Aug 18, 2026
P/E ratio
20.46
52-wk high
$859.34
52-wk low
$541.00
EPS
$40.45
Beta
0.20
Shares outstanding
101.14M
No. of employees
15K
News stories
From web sources and news partners
GlobeNewswire
·
16 hours ago
Robbins LLP Urges REGN Investors to Contact the Firm Before
The Motley Fool
·
17 hours ago
Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc
CEOLeonard Schleifer
Employees15.3K
Founded1988
HeadquartersTarrytown, New York, United States
SectorBiotechnology
Websiteregeneron.com